Commons Sense

Hansard-based summaries and metrics

<-- Back to proposed bills

Evaluation and Purchase of Antimicrobials

20 June 2022

Proposing MP
Sajid Javid Con
Bromsgrove
Type
Written Ministerial Statement
Department
Department of Health and Social Care
View on Parliament.uk -->

At a Glance

Issue Summary

The statement addresses the development and implementation of a new purchasing model for antibiotics to incentivise pharmaceutical companies to develop new antimicrobials.

Action Requested

I have signed contracts between NHS England and Improvement (NHSEI) and two pharmaceutical companies, Shionogi and Pfizer, for a 'subscription-style' payment model. I will also write to my counterparts in Scotland, Wales, and Northern Ireland inviting them to participate in the next steps of this project.

Key Facts

  • The Government has committed to develop a new purchasing model for antimicrobials that de-links payments from volumes used.
  • A joint project was launched by NHSEI, NICE, and DHSC in July 2019 to test a subscription-style payment for two antibiotics.
  • Payments for Cefiderocol (Shionogi) and Ceftazidime with Avibactam (Pfizer) will start on 1 July 2022.
  • The project is described as world-leading in incentivising innovation in antimicrobial drugs.
▸ Assessment & feedback
Summary accuracy